Novartis Considers Selling Generic Dermatology Drugs Business [Investor's Business Daily]
ADVANCED ACCELERATOR APPLICATIONS SA AMERICAN DE (AAAP)
Last advanced accelerator applications sa american de earnings: 8/31 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
adacap.com/investor-relations
Company Research
Source: Investors Business Daily
Technology Related news 10/31/2017 Mylan President Rajiv Malik was named in a sweeping lawsuit Tuesday alleging price-fixing. Incyte Rises On A Beat-And-Raise, Expanding Deal With AstraZeneca Lennar, Strayer, Dynegy Announce Deals; These May Be Next Biogen Dives Despite Topping Views; Lilly, Novartis Beat Does Gilead Now Have A New Multi-Billion-Dollar Franchise? Generic Drugmaker Soars 11%; Investors Warm Up To Merger Deal This Generic Drug Maker Dives As Much As 16% On Merger News Incyte Cancer Treatment Uses Patients' Immune System To Fight Disease Kite Pharma Cancer Treatment Stands Out In Hot CAR-T Field Novartis ( NVS ) is considering a sale of its dermatology generics drugs business as the Swiss health care giant seeks to shed some of its less profitable treatments and focus on growth areas such as cancer, according to people familiar with the matter. The business, which is mostly based in the U.S., could be valued at between
Show less
Read more
Impact Snapshot
Event Time:
AAAP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AAAP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AAAP alerts
High impacting ADVANCED ACCELERATOR APPLICATIONS SA AMERICAN DE news events
Weekly update
A roundup of the hottest topics